[{"AccountsPayableCurrent_0_Q2_USD":10455922.0,"PrepaidInsurance_0_Q2_USD":1325400.0,"PrepaidExpenseCurrentAndNoncurrent_0_Q2_USD":1548900.0,"PrepaidExpenseCurrent_0_Q2_USD":1548880.0,"PreferredStockValue_0_Q2_USD":null,"PreferredStockSharesOutstanding_0_Q2_shares":null,"PreferredStockSharesIssued_0_Q2_shares":null,"PreferredStockSharesAuthorized_0_Q2_shares":200000000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.001,"PaymentsToAcquireInvestments_2_Q2_USD":56872459.0,"ProceedsFromFeesReceived_2_Q2_USD":25000000.0,"OtherPrepaidExpenseCurrent_0_Q2_USD":76900.0,"OtherAssetsNoncurrent_0_Q2_USD":25000.0,"OtherAccruedLiabilitiesCurrentAndNoncurrent_0_Q2_USD":76400.0,"OperatingIncomeLoss_2_Q2_USD":-48867083.0,"OperatingIncomeLoss_1_Q2_USD":-26461880.0,"OperatingExpenses_2_Q2_USD":48867083.0,"OperatingExpenses_1_Q2_USD":26461880.0,"NonoperatingIncomeExpense_2_Q2_USD":99958.0,"NonoperatingIncomeExpense_1_Q2_USD":-90064.0,"NetIncomeLoss_2_Q2_USD":-48767125.0,"OtherDepreciationAndAmortization_2_Q2_USD":1300000.0,"NetIncomeLoss_1_Q2_USD":-26551944.0,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":23458050.0,"ProceedsFromWarrantExercises_2_Q2_USD":1941955.0,"UnrealizedGainLossOnInvestments_2_Q2_USD":-466444.0,"UnrealizedGainLossOnInvestments_1_Q2_USD":-289281.0,"StockholdersEquity_0_Q2_USD":96852557.0,"ShortTermInvestments_0_Q2_USD":104399140.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_0_Q2_USD":211653.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_0_Q2_shares":2670633.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_0_Q2_pure":0.0048,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_0_Q2_pure":1.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_0_Q2_pure":0.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":517271.0,"ShareBasedCompensation_2_Q2_USD":14119660.0,"ResearchAndDevelopmentExpense_2_Q2_USD":31353734.0,"ResearchAndDevelopmentExpense_1_Q2_USD":17331507.0,"RepaymentsOfNotesPayable_2_Q2_USD":null,"RealizedInvestmentGainsLosses_2_Q2_USD":-176379.0,"RealizedInvestmentGainsLosses_1_Q2_USD":-123590.0,"PropertyPlantAndEquipmentOther_0_Q2_USD":null,"PropertyPlantAndEquipmentNet_0_Q2_USD":null,"PropertyPlantAndEquipmentGross_0_Q2_USD":16700.0,"ProfitLoss_1_Q2_USD":-26551944.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-228082428.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-33296890.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":9553562.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":25917276.0,"CommonStockSharesAuthorized_0_Q2_shares":50000000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.001,"CommitmentsAndContingencies_0_Q2_USD":null,"ClassOfWarrantOrRightOutstanding_0_Q2_shares":4167.0,"ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_0_Q2_USD":34.35,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_2_Q2_USD":2173948.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":4669345.0,"Cash_0_Q2_USD":4669345.0,"AssetsCurrent_0_Q2_USD":110700210.0,"CommonStockSharesIssued_0_Q2_shares":17468819.0,"Assets_0_Q2_USD":110769300.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":14119700.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions_1_Q2_USD":8268376.0,"AdditionalPaidInCapital_0_Q2_USD":324917516.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":16700.0,"AccruedVacationCurrent_0_Q2_USD":414400.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":138800.0,"AccruedLiabilitiesCurrent_0_Q2_USD":3460821.0,"AccruedLiabilitiesAndOtherLiabilities_0_Q2_USD":3460800.0,"AccruedBonusesCurrentAndNoncurrent_0_Q2_USD":650200.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":7914039.0,"CommonStockSharesOutstanding_0_Q2_shares":17468819.0,"CommonStockValue_0_Q2_USD":17469.0,"ContractualObligation_0_Q2_USD":52800.0,"LiabilitiesCurrent_0_Q2_USD":13916743.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":110769300.0,"LeaseIncome_2_Q2_USD":6300.0,"InterestPaidNet_2_Q2_USD":null,"InterestIncomeOther_2_Q2_USD":8600.0,"InterestIncomeExpenseNet_2_Q2_USD":742781.0,"InterestIncomeExpenseNet_1_Q2_USD":322807.0,"IncreaseDecreaseInPrepaidExpense_2_Q2_USD":645690.0,"IncreaseDecreaseInLeasingReceivables_2_Q2_USD":-38899.0,"IncreaseDecreaseInAccruedLiabilities_2_Q2_USD":-796162.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":2109447.0,"GeneralAndAdministrativeExpense_2_Q2_USD":17513349.0,"GeneralAndAdministrativeExpense_1_Q2_USD":9130373.0,"GainLossOnSaleOfInvestments_2_Q2_USD":-66426021.0,"EmployeeStockOwnershipPlanESOPCompensationExpense_2_Q2_USD":78800.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-2.9,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-1.56,"Depreciation_2_Q2_USD":1258.0,"ContractualObligationDueInSecondYear_0_Q2_USD":null,"ContractualObligationDueInNextTwelveMonths_0_Q2_USD":52800.0,"ContractualObligationDueAfterFifthYear_0_Q2_USD":null,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":17054646.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":16814991.0,"Ticker":"RLMD","CIK":"1553643","name":"RELMADA THERAPEUTICS, INC.","OfficialName":"Relmada Therapeutics Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"772606380.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210810"}]